Constitutively Active Homo-oligomeric Angiotensin II Type 2 Receptor Induces Cell Signaling Independent of Receptor Conformation and Ligand Stimulation
Overview
Affiliations
Members of the G-protein-coupled receptor superfamily (GPCRs) undergo homo- and/or hetero-oligomerization to induce cell signaling. Although some of these show constitutive activation, it is not clear how such GPCRs undergo homo-oligomerization with transmembrane helix movement. We previously reported that angiotensin II (Ang II) type 2 (AT(2)) receptor, a GPCR, showed constitutive activation and induced apoptosis independent of its ligand, Ang II. In the present study, we analyzed the translocation and oligomerization of the AT(2) receptor with transmembrane movement when the receptor induces cell signaling. Constitutively active homo-oligomerization, which was due to disulfide bonding between Cys(35) in one AT(2) receptor and Cys(290) in another AT(2) receptor, was localized in the cell membrane without Ang II stimulation and induced apoptosis without changes in receptor conformation. These results provide the direct evidence that the constitutively active homo-oligomeric GPCRs by intermolecular interaction in two extracellular loops is translocated to the cell membrane and induces cell signaling independent of receptor conformation and ligand stimulation.
GPCR dimerization: Drug discovery aspects and targets in renin-angiotensin systems.
Faisal T, Hussain T FASEB Bioadv. 2025; 7(3):e1486.
PMID: 40060944 PMC: 11886600. DOI: 10.1096/fba.2024-00180.
Alternative Renin-Angiotensin System.
Bader M, Steckelings U, Alenina N, Santos R, Ferrario C Hypertension. 2024; 81(5):964-976.
PMID: 38362781 PMC: 11023806. DOI: 10.1161/HYPERTENSIONAHA.123.21364.
Colin M, Delaitre C, Foulquier S, Dupuis F Molecules. 2023; 28(14).
PMID: 37513355 PMC: 10383525. DOI: 10.3390/molecules28145481.
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.
Steckelings U, Widdop R, Sturrock E, Lubbe L, Hussain T, Kaschina E Pharmacol Rev. 2022; 74(4):1051-1135.
PMID: 36180112 PMC: 9553111. DOI: 10.1124/pharmrev.120.000281.
Perryman R, Renziehausen A, Shaye H, Kostagianni A, Tsiailanis A, Thorne T Proc Natl Acad Sci U S A. 2022; 119(32):e2116289119.
PMID: 35917342 PMC: 9371711. DOI: 10.1073/pnas.2116289119.